GRI Bio, Inc. (GRI) Dividend History

GRI Bio, Inc. is a biotechnology company focused on developing therapies targeting autoimmune and inflammatory diseases. The company leverages a proprietary platform to identify and develop novel biologics aimed at modulating immune responses, with an emphasis on improving patient outcomes in conditions with unmet medical needs.

2223 Avenida De La Playa, La Jolla, CA, 92037
Phone: (619) 400-1171
Website: https://www.gribio.com

Dividend History

GRI Bio, Inc. currently does not pay dividends

Company News

  • Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

    Windtree Therapeutics, a biotechnology company, announced the appointment of Leanne Kelly to its board of directors. Ms. Kelly has significant public company executive experience and will serve as an independent director and chair of the audit committee.

    GlobeNewswire Inc.
    Featured Companies: WINT
  • Top 4 Health Care Stocks That Are Preparing To Pump This Month

    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. ProSomnus, Inc. (NASDAQ: OSA) On Feb. 22, ...

    Benzinga
    Featured Companies: SINT
Page data last updated 07/23/2025 03:07:07 UTC